Advice
following an abbreviated submission
cefuroxime (Aprokam®) is accepted for use within NHS Scotland.
Indication under review: antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery.
Cefuroxime (Aprokam®) provides a licensed preparation and enables the off-label intracameral use of cefuroxime in cataract surgery to be avoided.
Download detailed advice50KB (PDF)
Medicine details
- Medicine name:
- cefuroxime (Aprokam)
- SMC ID:
- 932/13
- Indication:
- Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery.
- Pharmaceutical company
- Thea Pharmaceuticals
- BNF chapter
- Eye
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 12 December 2016